Home » Topics » Regulatory » EMA

EMA
RSS

Afamelanotide gains FDA and EMA orphan status for benign familial pemphigus

May 20, 2014

Anoro Ellipta approved in E.U. for COPD

May 9, 2014

C-Cure receives EMA certification of quality data

May 8, 2014

CHMP recommends variation to marketing authorization of Invega

April 29, 2014

EMA committee recommends approval of Mekinist

April 28, 2014

Boehringer Ingelheim's antithrombotic receives positive opinion from the EMA

April 28, 2014

EMA approves canagliflozin and metformin combination

April 28, 2014

Roche and Oryzon to develop epigenetics-based medicines

April 8, 2014

EMA validates Keryx Biopharmaceuticals' MAA for Zerenex

April 3, 2014

EMA validates MolMed's TK cell/gene therapy submission for conditional approval

March 31, 2014

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...